Vera Therapeutics, Inc. VERA
30.71 USD +0.46 (+1.52%)
At closeNov 3, 2026, 5:30 PM EST
31.31 +0.60 +1.95%
After hours · Nov 3, 5:30 PM ET
29.90 Day range 31.19
23.05 52-week range 56.05
- YTD
- -39.36%
- 1 year
- +18.39%
Financial health
Altman Z-Score
6.64 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E -10.9×
FY 2019 5y median -10.9× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 5.4×
FY 2019 5y median 5.4× FY 2025
P/FCF -13.5×
FY 2019 5y median -13.5× FY 2025
EV/EBITDA -10.2×
FY 2019 5y median -8.8× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -7.4%
FY 2019 5y median -7.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -49.6%
FY 2019 5y median -49.6% FY 2025
ROIC -46.3%
FY 2019 5y median -46.3% FY 2025
ROA -40.8%
FY 2019 5y median -40.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -88.7%
FY 2019 FY 2025
EPS (diluted) -69.5%
FY 2019 FY 2025
Free Cash Flow -78.2%
FY 2019 FY 2025
Financial Health
Current Ratio 13.6×
FY 2019 5y median 10.7× FY 2025
Quick Ratio 13.6×
FY 2019 5y median 10.7× FY 2025
Debt / Equity 0.1×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 1.0×
FY 2019 5y median 0.3× FY 2025
Interest Coverage -41.9×
FY 2019 5y median -41.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31